Works matching AU Visseren-Grul, Carla

Results: 18

A Phase II Randomized Study of Cisplatin-Pemetrexed plus either Enzastaurin or Placebo in Chemonaive Patients with Advanced Non-Small Cell Lung Cancer.

Published in:

Oncology, 2012, v. 82, n. 1, p. 25, doi. 10.1159/000335268

By:

Vansteenkiste, Johan;
Ramlau, Rodryg;
von Pawel, Joachim;
San Antonio, Belen;
Eschbach, Corinna;
Szczesna, Aleksandra;
Kennedy, Liam;
Visseren-Grul, Carla;
Chouaki, Nadia;
Reck, Martin

Publication type:

Article

RELAY, Ramucirumab Plus Erlotinib Versus Placebo Plus Erlotinib in Patients with Untreated, Epidermal Growth Factor Receptor Mutation-Positive, Metastatic Non-Small-Cell Lung Cancer: Safety Profile and Manageability.

Published in:

Drug Safety, 2022, v. 45, n. 1, p. 45, doi. 10.1007/s40264-021-01127-2

By:

Nadal, Ernest;
Horinouchi, Hidehito;
Shih, Jin-Yuan;
Nakagawa, Kazuhiko;
Reck, Martin;
Garon, Edward B.;
Wei, Yu-Feng;
Kollmeier, Jens;
Frimodt-Moller, Bente;
Barrett, Emily;
Lipkovich, Olga;
Visseren-Grul, Carla;
Novello, Silvia

Publication type:

Article

Ramucirumab or placebo plus erlotinib in EGFR‐mutated, metastatic non‐small‐cell lung cancer: East Asian subset of RELAY.

Published in:

Cancer Science, 2020, v. 111, n. 12, p. 4510, doi. 10.1111/cas.14655

By:

Nishio, Makoto;
Seto, Takashi;
Reck, Martin;
Garon, Edward B.;
Chiu, Chao‐Hua;
Yoh, Kiyotaka;
Imamura, Fumio;
Park, Keunchil;
Shih, Jin‐Yuan;
Visseren‐Grul, Carla;
Frimodt‐Moller, Bente;
Zimmermann, Annamaria;
Homma, Gosuke;
Enatsu, Sotaro;
Nakagawa, Kazuhiko

Publication type:

Article

RELAY, ramucirumab plus erlotinib versus placebo plus erlotinib in untreated EGFR-mutated metastatic non-small cell lung cancer: exposure-response relationship.

Published in:

2022

By:

Nakagawa, Kazuhiko;
Garon, Edward B.;
Gao, Ling;
Callies, Sophie;
Zimmermann, Annamaria;
Walgren, Richard;
Visseren-Grul, Carla;
Reck, Martin

Publication type:

journal article

Home administration of maintenance pemetrexed for patients with advanced non-squamous non-small cell lung cancer: rationale, practicalities and phase II feasibility study design.

Published in:

2013

By:

Lal, Rohit;
Bourayou, Nawel;
Hillerdal, Gunnar;
Nicolson, Marianne;
Vikstrom, Anders;
Lorenzo, Maria;
D'yachkova, Yulia;
Barriga, Susana;
Visseren-Grul, Carla

Publication type:

journal article

Patient-reported outcomes in RELAY, a phase 3 trial of ramucirumab plus erlotinib versus placebo plus erlotinib in untreated EGFR-mutated metastatic non-small-cell lung cancer.

Published in:

Current Medical Research & Opinion, 2020, v. 36, n. 10, p. 1667, doi. 10.1080/03007995.2020.1808781

By:

Yoh, Kiyotaka;
Atagi, Shinji;
Reck, Martin;
Garon, Edward B.;
Ponce Aix, Santiago;
Moro-Sibilot, Denis;
Winfree, Katherine B.;
Frimodt-Moller, Bente;
Zimmermann, Annamaria;
Visseren-Grul, Carla;
Nakagawa, Kazuhiko

Publication type:

Article

RELAY, Ramucirumab Plus Erlotinib (RAM+ERL) in Untreated Metastatic EGFR-Mutant NSCLC (EGFR+ NSCLC): Association Between TP53 Status and Clinical Outcome.

Published in:

Clinical Lung Cancer, 2023, v. 24, n. 5, p. 415, doi. 10.1016/j.cllc.2023.02.010

By:

Makoto Nishio;
Paz-Ares, Luis;
Reck, Martin;
Kazuhiko Nakagawa;
Garon, Edward B.;
Popat, Sanjay;
Ceccarelli, Matteo;
Graham, Hillary T.;
Visseren-Grul, Carla;
Novello, Silvia

Publication type:

Article

Safety Analyses of Pemetrexed-cisplatin and Pemetrexed Maintenance Therapies in Patients With Advanced Non-squamous NSCLC: Retrospective Analyses From 2 Phase III Studies.

Published in:

2017

By:

Langer, Corey J.;
Paz-Ares, Luis G.;
Wozniak, Antoinette J.;
Gridelli, Cesare;
de Marinis, Filippo;
Pujol, Jean-Louis;
Antonio, Belen San;
Jian Chen;
Jingyi Liu;
Oton, Ana B.;
Visseren-Grul, Carla;
Scagliotti, Giorgio V.;
San Antonio, Belen;
Chen, Jian;
Liu, Jingyi

Publication type:

journal article

Long-Term and Low-Grade Safety Results of a Phase III Study (PARAMOUNT): Maintenance Pemetrexed Plus Best Supportive Care Versus Placebo Plus Best Supportive Care Immediately After Induction Treatment With Pemetrexed Plus Cisplatin for Advanced Nonsquamous Non--Small-Cell Lung Cancer.

Published in:

Clinical Lung Cancer, 2014, v. 15, n. 6, p. 418, doi. 10.1016/j.cllc.2014.06.007

By:

Pujol, Jean-Louis;
Paz-Ares, Luis;
de Marinis, Filippo;
Dediu, Mircea;
Thomas, Michael;
Bidoli, Paolo;
Corral, Jesus;
San Antonio, Belen;
Chouaki, Nadia;
John, William;
Zimmermann, Annamaria;
Visseren-Grul, Carla;
Gridelli, Cesare

Publication type:

Article

Pemetrexed use in the adjuvant setting for completely resectable non-small-cell lung cancer.

Published in:

2013

By:

Simon, George R;
Manegold, Christian;
Barker, Scott S;
Treat, Joseph A;
Visseren-Grul, Carla;
Obasaju, Coleman

Publication type:

Journal Article

Pemetrexed Use in the Adjuvant Setting for Completely Resectable Non—Small-Cell Lung Cancer.

Published in:

Clinical Lung Cancer, 2013, v. 14, n. 6, p. 601, doi. 10.1016/j.cllc.2013.06.001

By:

Simon, George R.;
Manegold, Christian;
Barker, Scott S.;
Treat, Joseph A.;
Visseren-Grul, Carla;
Obasaju, Coleman

Publication type:

Article

Evaluation of changes in renal function in PARAMOUNT: a phase III study of maintenance pemetrexed plus best supportive care versus placebo plus best supportive care after induction treatment with pemetrexed plus cisplatin for advanced nonsquamous non-small-cell lung cancer.

Published in:

2018

By:

Middleton, Gary;
Gridelli, Cesare;
De Marinis, Filippo;
Pujol, Jean-Louis;
Reck, Martin;
Ramlau, Rodryg;
Parente, Barbara;
Pieters, Thierry;
Visseren-Grul, Carla M.;
San Antonio, Bélen;
John, William J.;
Zimmermann, Annamaria Hayden;
Chouaki, Nadia;
Paz-Ares, Luis

Publication type:

journal article

Second-line therapy for NSCLC in clinical practice: baseline results of the European SELECTTION observational study.

Published in:

2010

By:

Moro-Sibilot, Denis;
Vergnenegre, Alain;
Smit, Egbert F;
Toy, Elisabeth;
Parente, Barbara;
Schmitz, Stephan;
Kraaij, Kees;
Visseren-Grul, Carla;
Soldatenkova, Victoria;
Arellano, Jorge;
Leteneux, Claudia

Publication type:

Journal Article

TP53 Co-Mutation Status Association with Clinical Outcomes in Patients with EGFR -Mutant Non-Small Cell Lung Cancer.

Published in:

Cancers, 2022, v. 14, n. 24, p. 6127, doi. 10.3390/cancers14246127

By:

Le, Xiuning;
Molife, Cliff;
Leusch, Mark S.;
Rizzo, Maria Teresa;
Peterson, Patrick M.;
Caria, Nicola;
Chen, Yongmei;
Gugel, Elena Gonzalez;
Visseren-Grul, Carla

Publication type:

Article

Treatment rationale and study design for a phase III, double-blind, placebo-controlled study of maintenance pemetrexed plus best supportive care versus best supportive care immediately following induction treatment with pemetrexed plus cisplatin for advanced nonsquamous non-small cell lung cancer.

Published in:

2010

By:

Paz-Ares LG;
Altug S;
Vaury AT;
Jaime JC;
Russo F;
Visseren-Grul C;
Paz-Ares, Luis G;
Altug, Sedat;
Vaury, Alexandra Thareau;
Jaime, Jesús Corral;
Russo, Francesca;
Visseren-Grul, Carla

Publication type:

journal article

Treatment rationale and study design for a phaseIII, double-blind, placebo-controlled study ofmaintenance pemetrexed plus best supportivecare versus best supportive care immediatelyfollowing induction treatment with pemetrexedplus cisplatin for advanced nonsquamousnon-small cell lung cancer

Published in:

BMC Cancer, 2010, v. 10, p. 85, doi. 10.1186/1471-2407-10-85

By:

Paz-Ares, Luis G.;
Altug, Sedat;
Vaury, Alexandra Thareau;
Jaime, Jesús Corral;
Russo, Francesca;
Visseren-Grul, Carla

Publication type:

Article

Association between Gene Expression Profiles and Clinical Outcome of Pemetrexed-Based Treatment in Patients with Advanced Non-Squamous Non-Small Cell Lung Cancer: Exploratory Results from a Phase II Study.

Published in:

PLoS ONE, 2014, v. 9, n. 9, p. 1, doi. 10.1371/journal.pone.0107455

By:

Fennell, Dean A.;
Myrand, Scott P.;
Nguyen, Tuan S.;
Ferry, David;
Kerr, Keith M.;
Maxwell, Perry;
Moore, Stephen D.;
Visseren-Grul, Carla;
Das, Mayukh;
Nicolson, Marianne C.

Publication type:

Article

Clinical outcomes of ramucirumab plus docetaxel in the treatment of patients with non-small cell lung cancer after immunotherapy: a systematic literature review.

Published in:

Frontiers in Oncology, 2023, p. 01, doi. 10.3389/fonc.2023.1247879

By:

Garon, Edward B.;
Visseren-Grul, Carla;
Rizzo, Maria Teresa;
Puri, Tarun;
Chenji, Suresh;
Reck, Martin

Publication type:

Article